These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 7995636

  • 21. Urinary kallikrein in Dahl-Iwai salt-sensitive and -resistant rats.
    Yoshida H, Nakagawa M, Aoyama T, Takizawa H, Higashiura K, Ura N, Shimamoto K.
    Am J Hypertens; 1997 May; 10(5 Pt 2):73S-77S. PubMed ID: 9160785
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Interferon gamma attenuates hypertensive renal injury in salt-sensitive Dahl rats.
    Ishimitsu T, Uehara Y, Numabe A, Tsukada H, Ogawa Y, Iwai J, Ikeda T, Matsuoka H, Sugimoto T, Yagi S.
    Hypertension; 1992 Jun; 19(6 Pt 2):804-8. PubMed ID: 1592485
    [Abstract] [Full Text] [Related]

  • 25. Renal cyclic 3',5'-guanosine monophosphate and sodium excretion in Dahl salt-resistant and Dahl salt-sensitive rats: comparison of the roles of bradykinin and nitric oxide.
    Millatt LJ, Siragy HM.
    J Hypertens; 2000 Oct; 18(10):1491-6. PubMed ID: 11057438
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Regulatory effects of salt diet on renal renin-angiotensin-aldosterone, and kallikrein-kinin systems.
    Hettinger U, Lukasova M, Lewicka S, Hilgenfeldt U.
    Int Immunopharmacol; 2002 Dec; 2(13-14):1975-80. PubMed ID: 12489811
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Kallikrein-kinin system and blood pressure sensitivity to salt.
    Madeddu P, Varoni MV, Demontis MP, Chao J, Simson JA, Glorioso N, Anania V.
    Hypertension; 1997 Jan; 29(1 Pt 2):471-7. PubMed ID: 9039144
    [Abstract] [Full Text] [Related]

  • 34. Interactions of the kallikrein-kinin and renin-angiotensin systems in experimental diabetes.
    Vora JP, Oyama TT, Thompson MM, Anderson S.
    Diabetes; 1997 Jan; 46(1):107-12. PubMed ID: 8971089
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Hachimi-jio-gan extract protects the kidney from hypertensive injury in Dahl salt-sensitive rat.
    Hirawa N, Uehara Y, Kawabata Y, Numabe A, Takada S, Nagoshi H, Gomi T, Ikeda T, Omata M.
    Am J Chin Med; 1996 Jan; 24(3-4):241-54. PubMed ID: 8982436
    [Abstract] [Full Text] [Related]

  • 38. A new adenosine subtype-1 receptor antagonist, FK-838, attenuates salt-induced hypertension in Dahl salt-sensitive rats.
    Uehara Y, Numabe A, Hirawa N, Kawabata Y, Nagoshi H, Kaneko H, Gomi T, Goto A, Toyo-oka T, Omata M.
    Am J Hypertens; 1995 Dec; 8(12 Pt 1):1189-99. PubMed ID: 8998253
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Human tissue kallikrein gene delivery attenuates hypertension, renal injury, and cardiac remodeling in chronic renal failure.
    Wolf WC, Yoshida H, Agata J, Chao L, Chao J.
    Kidney Int; 2000 Aug; 58(2):730-9. PubMed ID: 10916096
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.